Silkworm Pupa Powder Improves Dementia.
A Prospective, Double-Blind, Randomized Controlled Trial Evaluating Silkworm Pupa Powder Versus Placebo in Improving Alzheimer's Disease Among Patients
Sponsor: Hangzhou Institute of Medicine Chinese Academy of Sciences
This NA trial investigates Alzheimer Disease(AD) and Asthenia and is currently actively recruiting participants. Hangzhou Institute of Medicine Chinese Academy of Sciences leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
-
May 2025 — Jun 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2025 — May 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hangzhou Institute of Medicine Chinese Academy of Sciences
- Zhejiang Provincial Tongde Hospital
For direct contact, visit the study record on ClinicalTrials.gov .